ArticleNature communications2017
Extrafollicular CD4
Open access · goldAbstract read
In one paragraph
Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.
0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 64 citations in OpenAlex.
- Bone marrow-inspired DLL1-presenting microparticles enhance asymmetric division and maintenance of mouse hematopoietic stem and progenitor cells.Stem cell reports · 2026Article
- Stem-like memory-T maintenance and differentiation into tissue-resident T cells sustain chronic graft-versus-host disease in mice.Nature communications · 2026Article
- T cell-macrophage crosstalk in GVHD and cancer immunotherapy.Cell investigation · 2025Article
- Chronic Graft-versus-host Disease, Part 1: How Preclinical Models Shape Our Understanding of Biology and Pave the Way for Future Therapeutic Interventions.Transplantation · 2025Review
- What's atypical about human B cells after allogeneic stem cell transplantation?Journal of leukocyte biology · 2025Review
- Lupus-like manifestations after allogenic hematopoietic stem cell transplantation: a rare case of chronic graft-versus-host disease.Journal of nephrology · 2025Article
- Coordinated Regulation of Extrafollicular B Cell Responses by IL-12 and IFNγ.Immunological reviews · 2025Review
- [Effects of donor T cell stat3 deficiency on acute intestinal graft-versus-host disease in mice].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025Article
- Signaling Activation and Modulation in Extrafollicular B Cell Responses.Immunological reviews · 2025Review
- Contribution of long-lived plasma cells to antibody-mediated allograft rejection.Clinical transplantation and research · 2024Review
- A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy.Biomarker research · 2024Review
- Germinal center versus extrafollicular responses in systemic autoimmunity: Who turns the blade on self?Advances in immunology · 2024Review
- Mesenchymal stromal cells ameliorate chronic GVHD by boosting thymic regeneration in a CCR9-dependent manner in mice.Blood advances · 2023Article
- Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity.The Journal of clinical investigation · 2023Article
- Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.JCI insight · 2023Article
- Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023Article
- Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT.Frontiers in immunology · 2023Review
- Complex interactions of cellular players in chronic Graft-versus-Host Disease.Frontiers in immunology · 2023Review
- Article
- Targeting TNature immunology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 5 institutions in 2 countries.
Ruishu DengDiabetes and Metabolism Research Institute, The Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.
Christian HurtzDepartment of Laboratory Medicine, University of California, San Francisco, CA, 94143, USA.
Qingxiao SongDiabetes and Metabolism Research Institute, The Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.
Chanyu YueDepartment of Cancer Immunotherapeutic and Tumor Immunology, The Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.
Gang XiaoDepartment of Laboratory Medicine, University of California, San Francisco, CA, 94143, USA.
Hua YuDepartment of Cancer Immunotherapeutic and Tumor Immunology, The Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.
Xiwei WuDepartment of Molecular and Cellular Biology, The Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.
Markus MuschenDepartment of Laboratory Medicine, University of California, San Francisco, CA, 94143, USA.
Stephen FormanHematologic Malignancies and Stem Cell Transplantation Institute, The Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.
Paul J MartinFred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, 98109, USA.
Defu ZengDiabetes and Metabolism Research Institute, The Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA. dzeng@coh.org.ORCID http://orcid.org/0000-0001-9585-1411
City of Hope · USUniversity of California, San Francisco · USFujian Medical University · CNSanford Burnham Prebys Medical Discovery Institute · USUniversity of Washington · US
Funding
Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3MMetabolic gatekeepers in B-cell malignanciesR35CA197628 · NCI · YALE UNIVERSITY · PI Markus Müschen · 2016 to 2026
$11.7MRole of autoreactivity in the pathogenesis of chronic GVHDR01AI066008 · NIAID · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI ZENG, DEFU · 2005 to 2020
$6.1MCD25-mediated feedback control of BCR-signaling and its oncogenic mimicsR01CA213138 · NCI · YALE UNIVERSITY · PI MÜSCHEN, MARKUS · 2017 to 2022
$1.9MRole of autoreactivity in the pathogenesis of chronic GVHDR56AI066008 · NIAID · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI ZENG, DEFU · 2015 to 2021
$777kNCI NIH HHS P30 CA033572NCI NIH HHS R01 CA213138NCI NIH HHS R35 CA197628NIAID NIH HHS R01 AI066008NIAID NIH HHS R56 AI066008
Abstract
Chronic graft-versus-host disease (cGVHD) is an autoimmune-like syndrome mediated by pathogenic CD4
Indexed as
AnimalsAutoimmune DiseasesB-LymphocytesCD4-Positive T-LymphocytesChronic DiseaseGerminal CenterGraft vs Host DiseaseHumansMaleMiceMice, Inbred BALB CMice, Inbred C57BLProto-Oncogene Proteins c-bcl-6STAT3 Transcription FactorT-Lymphocytes, Helper-InducerBcl6 protein, mouseProto-Oncogene Proteins c-bcl-6Stat3 protein, mouseSTAT3 Transcription Factor
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.